Published in J Transl Med on September 23, 2016
Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation | NCT01919346
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration (OPERA) | NCT00851409
Complement. Second of two parts. N Engl J Med (2001) 6.32
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol (2009) 1.81
Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation (2001) 1.64
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant (2014) 1.61
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) (2013) 1.40
The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol (2012) 1.29
Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol (2011) 1.26
The role of complement in the early immune response to transplantation. Nat Rev Immunol (2012) 1.26
Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med (2001) 1.18
Complement in ischemia reperfusion injury. Am J Pathol (2003) 1.15
A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol (2005) 1.14
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol (2010) 1.12
C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost (2010) 1.09
Organ reperfusion and preservation. Front Biosci (2008) 1.06
Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther (1998) 1.06
Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant (2009) 0.96
Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J Immunol (2001) 0.95
Circulating AST, H-FABP, and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation. Ann Surg (2011) 0.89
Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol (2000) 0.88
Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits. J Biotechnol (2012) 0.87
Targeting complement at the time of transplantation. Adv Exp Med Biol (2013) 0.86
Mechanisms of rejection: role of complement. Curr Opin Organ Transplant (2014) 0.86
Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction. Am J Transplant (2013) 0.86
Biochemistry and pathophysiology of human C1 inhibitor: current issues. Complement (1985) 0.84
Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema. Br J Clin Pharmacol (2013) 0.81
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Clin Exp Allergy (2012) 0.80
Analysis of low molecular weight intracellular associations of a human mannan binding lectin (MBL). Mol Immunol (2004) 0.79
Kidney graft outcome using an anti-Xa therapeutic strategy in an experimental model of severe ischaemia-reperfusion injury. Br J Surg (2014) 0.77
C1-esterase inhibitor reduces reperfusion injury after lung transplantation. Ann Thorac Surg (2002) 0.77
Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation. Am J Transplant (2014) 0.77
Correlation of changes in blood chemistry with pathological changes in the animal's body: II Electrolytes, kidney function tests, serum enzymes, and liver function tests. J S Afr Vet Assoc (1981) 0.77
Mechanistic analysis of nonoxygenated hypothermic machine perfusion's protection on warm ischemic kidney uncovers greater eNOS phosphorylation and vasodilation. Am J Transplant (2014) 0.76